Despite controlling for several variables, we identified sets of CSF lipids that were associated with each AD biomarker and MCI to AD progression, suggesting that the role of lipids in AD pathology and progression is broader than their possible role in the development of pathological hallmarks of AD and the influence of APOE ɛ4. This evidence concerns the gene APOE and Alzheimer disease.